KR102922546B1 - 외상 후 면역 억제의 치료 또는 예방에 사용하기 위한 조류 추출물 - Google Patents

외상 후 면역 억제의 치료 또는 예방에 사용하기 위한 조류 추출물

Info

Publication number
KR102922546B1
KR102922546B1 KR1020217012097A KR20217012097A KR102922546B1 KR 102922546 B1 KR102922546 B1 KR 102922546B1 KR 1020217012097 A KR1020217012097 A KR 1020217012097A KR 20217012097 A KR20217012097 A KR 20217012097A KR 102922546 B1 KR102922546 B1 KR 102922546B1
Authority
KR
South Korea
Prior art keywords
ulva
extract
cells
sulfated
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217012097A
Other languages
English (en)
Korean (ko)
Other versions
KR20210114921A (ko
Inventor
카림 아쉬눈
세드릭 잭클린
마르완 부라스
앙트완 로퀼리
피 니발-콜렌
에흐비 드메
에흐비 발루송
Original Assignee
아마데이테
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아마데이테 filed Critical 아마데이테
Publication of KR20210114921A publication Critical patent/KR20210114921A/ko
Application granted granted Critical
Publication of KR102922546B1 publication Critical patent/KR102922546B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
KR1020217012097A 2018-10-22 2019-10-22 외상 후 면역 억제의 치료 또는 예방에 사용하기 위한 조류 추출물 Active KR102922546B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1859721A FR3087338B1 (fr) 2018-10-22 2018-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
FR1859721 2018-10-22
PCT/EP2019/078757 WO2020083931A1 (fr) 2018-10-22 2019-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique

Publications (2)

Publication Number Publication Date
KR20210114921A KR20210114921A (ko) 2021-09-24
KR102922546B1 true KR102922546B1 (ko) 2026-02-04

Family

ID=65494363

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217012097A Active KR102922546B1 (ko) 2018-10-22 2019-10-22 외상 후 면역 억제의 치료 또는 예방에 사용하기 위한 조류 추출물

Country Status (10)

Country Link
US (1) US12377126B2 (https=)
EP (2) EP3870198B1 (https=)
JP (1) JP7614105B2 (https=)
KR (1) KR102922546B1 (https=)
CN (1) CN113347984A (https=)
AU (2) AU2019364677B2 (https=)
CA (1) CA3116952A1 (https=)
FR (1) FR3087338B1 (https=)
IL (1) IL282511B1 (https=)
WO (1) WO2020083931A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114376233A (zh) * 2022-03-23 2022-04-22 青岛海大生物集团股份有限公司 一种具有增强免疫功能的浒苔多糖保健食品及制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016539184A (ja) * 2013-11-18 2016-12-15 アマデイト 免疫調節剤としての用いるための藻類抽出物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7132101B2 (en) 2002-02-27 2006-11-07 Duquesne University Of The Holy Ghost Compositions and methods for eliciting an immune response to gram-negative bacterial infections
NZ542791A (en) 2003-04-08 2008-04-30 Biotempt Bv Compositions for mucosal and oral administration comprising HCG fragments
RU2417093C2 (ru) 2005-06-24 2011-04-27 Дезерт Лейк Текнолоджиз Очищенный компонент цианобактерий и способ применения
ATE514950T1 (de) 2007-09-07 2011-07-15 Univ Zuerich Verfahren zur untersuchung von sepsis bei menschen
KR101102829B1 (ko) * 2008-09-12 2012-01-05 재단법인 제주테크노파크 구멍갈파래 추출물과 그것의 항염증제로서의 용도
US9370537B2 (en) * 2009-04-03 2016-06-21 Cerule, Llc Compositions and methods for reducing inflammation
FR2954703B1 (fr) * 2009-12-28 2013-12-13 Chu Nantes Agonistes des recepteurs tlr 4 et 9 pour prevenir les complications septiques de l'immunodepression post-traumatique chez les patients hospitalises pour traumatismes severes
US20130102662A1 (en) * 2011-06-09 2013-04-25 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of inducible nitric oxide synthase inhibitors and nitric oxide scavengers to inhibit post-traumatic immunodepression
FR2999084B1 (fr) * 2012-12-11 2015-03-13 Amadeite Extrait d'algues comprenant en particulier des polysaccharides polyanioniques sulfates et non sulfates et ses applications
FR3013223B1 (fr) * 2013-11-18 2016-09-02 Amadeite Extrait d'algues pour son utilisation en tant qu'agent anti-bacterien

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016539184A (ja) * 2013-11-18 2016-12-15 アマデイト 免疫調節剤としての用いるための藻類抽出物

Also Published As

Publication number Publication date
US20210386808A1 (en) 2021-12-16
US12377126B2 (en) 2025-08-05
AU2019364677A1 (en) 2021-05-20
AU2025200105A1 (en) 2025-01-23
BR112021007506A2 (pt) 2021-07-27
IL282511A (en) 2021-06-30
JP2022508900A (ja) 2022-01-19
WO2020083931A1 (fr) 2020-04-30
EP4483961A3 (fr) 2025-03-19
EP4483961A2 (fr) 2025-01-01
FR3087338B1 (fr) 2020-10-09
EP3870198C0 (fr) 2024-11-20
EP3870198A1 (fr) 2021-09-01
JP7614105B2 (ja) 2025-01-15
KR20210114921A (ko) 2021-09-24
IL282511B1 (en) 2026-02-01
EP3870198B1 (fr) 2024-11-20
CA3116952A1 (fr) 2020-04-30
FR3087338A1 (fr) 2020-04-24
AU2019364677B2 (en) 2024-10-10
CN113347984A (zh) 2021-09-03

Similar Documents

Publication Publication Date Title
KR101826071B1 (ko) 포유동물 체내에서 유래된 세포밖 소포체를 포함하는 조성물 및 이의 용도
RU2628536C2 (ru) Получение и применение бактериального гистамина
EP1461054B1 (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
KR101618330B1 (ko) 락토코커스 중앙젠시스를 유효성분으로 함유하는 염증성 질환의 예방 또는 치료용 약학적 조성물
JP2017514922A (ja) 高分子多糖バインダーにコンジュゲートされたラクトバシラスラムノサスｒｈｔ−３２０１、及びこれのアトピー予防及び治療用途
AU2025200105A1 (en) Algal extract for use in the treatment or prevention of post-traumatic immunosuppression
KR102252124B1 (ko) 소태나무 추출물을 이용한 호흡기 질환 개선용 조성물
JP2022508900A5 (https=)
JP6708376B2 (ja) ＩＦＮ−γ及び／又はＩＬ−１７の産生抑制剤、並びにＴｈ１細胞及び／又はＴｈ１７細胞の分化抑制剤
BR112021007506B1 (pt) Uso de um extrato de algas verdes do tipo ulva
KR101094194B1 (ko) 아토피성 피부염 치료 및/또는 예방용 유산균 및 이를함유하는 조성물
KR101722448B1 (ko) 암라 열매 추출물 및 구아바 잎 추출물을 함유하는 면역증강용 식품조성물
WO2007066313A2 (en) Compositions and methods for modulating an immune response
KR102893878B1 (ko) 더위지기 추출물을 포함하는 면역증강용 조성물
KR101424105B1 (ko) 봉독을 포함하는 피부 소양증 개선용 조성물
KR101828044B1 (ko) 수지상 세포 및 항생제를 포함하는 결핵 예방 또는 치료용 조성물
CN117562884A (zh) 赖氨酸抑制金黄色葡萄球菌溶血素的用途
JP2021187769A (ja) 免疫制御用組成物
KR20210111057A (ko) 염증 질환 또는 면역 질환의 예방 또는 치료용 약학적 조성물
HK1067073B (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D22-EXM-PE0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

U12 Designation fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)